Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
0.2200
+0.0200 (10.00%)
At close: Jan 2, 2026, 4:00 PM EST
0.1931
-0.0269 (-12.23%)
After-hours: Jan 2, 2026, 8:00 PM EST
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of $24.66 million as of January 2, 2026. Its market cap has increased by 55.53% in one year.
Market Cap
24.66M
Enterprise Value
17.92M
1-Year Change
55.53%
Ranking
Category
Stock Price
$0.22
Market Cap Chart
Since June 12, 2006, Can-Fite BioPharma's market cap has increased from $3.58M to $24.66M, an increase of 588.77%. That is a compound annual growth rate of 10.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 1, 2026 | 24.66M | 0.07% |
| Dec 31, 2025 | 24.64M | 58.34% |
| Dec 31, 2024 | 15.56M | 75.98% |
| Dec 31, 2023 | 8.84M | -54.56% |
| Dec 29, 2022 | 19.46M | -49.59% |
| Dec 30, 2021 | 38.60M | 34.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |